Nasdaq First North
Every company in the roster listed on Nasdaq First North.
Every company in the roster listed on Nasdaq First North.
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Alzinova ABALZ · Nasdaq First North | 1 asset: 1 Ph 1 | ALZ-101Phase 1 · Alzheimer's DiseasePartial signal | None on record | — | — | — | — |
Pila PharmaPILA · Nasdaq First North | 1 asset: 1 Ph 2 | XEN-D0501Phase 2 · Type 2 DiabetesPartial signal | None on record | — | $1.7MDec 2025 | Ended Apr 2026 | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.